AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $136,595 | +5.2% | 5,519 | +20.3% | 0.01% | 0.0% |
| Q2 2023 | $129,904 | +34.7% | 4,587 | +9.2% | 0.01% | +25.0% |
| Q1 2023 | $96,474 | -20.2% | 4,200 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $120,960 | +2.5% | 4,200 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $118,000 | +26.9% | 4,200 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $93,000 | -23.8% | 4,200 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $122,000 | -11.6% | 4,200 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $138,000 | -34.0% | 4,200 | -7.1% | 0.01% | -37.5% |
| Q3 2021 | $209,000 | -21.4% | 4,521 | -6.4% | 0.01% | -20.0% |
| Q2 2021 | $266,000 | – | 4,830 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |